Display options
Share it on

Surg Neurol Int. 2017 Oct 24;8:S37-S42. doi: 10.4103/sni.sni_286_17. eCollection 2017.

[Comparative analysis of Grade I vs Grade II intracranial Meningiomas in a retrospective series of 63 patients].

Surgical neurology international

[Article in Spanish]
Federico Coppola, Juan Iaconis Campbell, Juan Manuel Herrero, Emilio Volpe, Tito Cersosimo

Affiliations

  1. Hospital Nacional Prof. Alejandro Posadas, Buenos Aires, Argentina.

PMID: 29142779 PMCID: PMC5672660 DOI: 10.4103/sni.sni_286_17

Abstract

OBJECTIVE: We aimed to demonstrate the differences between grade I and II (OMS classification) of intracranial meningiomas. We evaluate their location, Simpson resection grade, re-operations rate, adjuvant treatment and patient outcomes.

METHODS: We conduct a retrospective review of Sixty- three clinical records of patients who were diagnosed with meningiomas grade I and II (OMS) between 2009-2015 and received surgical treatment at our Hospital. We evaluated different variables such as age, sex, histological type, Simpson grade resection, location, symptoms, radiotherapy, follow-up, mortality rate and patient outcome. The main aim was to establish the differences between these intracranial tumors.

RESULTS: A total of sixty-three patients diagnosed with meningiomas and received surgical treatment; fifty-one were grade I and thirteen with grade II. There were no differences in the rate between man and women. The average age for both types of meningiomas was 57 years old. The typical meningiomas were located in 55% of the cases outside the cranial base vs. 91.6% of the atypical meningiomas (

CONCLUSIONS: The atypical intracranial meningiomas have a worse outcome compared with the typical kind and a higher incidence of re-operations. These tumors have a preference for a location outside the cranial base. Concluding that the location could be a risk factor.

Conflict of interest statement

There are no conflicts of interest.

References

  1. Acta Neuropathol. 2016 Jun;131(6):803-20 - PubMed
  2. J Neurosurg. 1997 May;86(5):793-800 - PubMed
  3. Neurosurg Clin N Am. 2016 Apr;27(2):239-47 - PubMed
  4. J Neurosurg. 1992 Oct;77(4):616-23 - PubMed
  5. Int J Clin Exp Pathol. 2012;5(3):231-42 - PubMed
  6. Cancer. 1998 Jun 1;82(11):2262-9 - PubMed
  7. J Neurosurg. 2001 Oct;95(4):601-7 - PubMed
  8. Neurosurgery. 2004 Jan;54(1):55-63; discussion 63-4 - PubMed
  9. Neurosurgery. 2007 Dec;61(6):1194-8; discussion 1198 - PubMed
  10. Cancer. 2011 Mar 15;117(6):1272-8 - PubMed
  11. J Neurosurg. 2011 Oct;115(4):811-9 - PubMed
  12. Am J Clin Oncol. 2005 Feb;28(1):70-4 - PubMed
  13. Int J Radiat Oncol Biol Phys. 2000 Jan 1;46(1):57-61 - PubMed
  14. Trials. 2015 Nov 14;16:519 - PubMed
  15. Surg Neurol. 1986 Nov;26(5):461-9 - PubMed

Publication Types